We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-14.3%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$85.3B
AUM Growth
-$21.5B
Cap. Flow
-$8.25B
Cap. Flow %
-9.67%
Top 10 Hldgs %
8.52%
Holding
6,080
New
595
Increased
1,779
Reduced
1,835
Closed
791

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Financials 10.48%
3 Healthcare 7.82%
4 Consumer Discretionary 7.11%
5 Communication Services 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLSI icon
4476
Greenwich LifeSciences
GLSI
$282M
$149K ﹤0.01%
+17,631
New +$202K
MERC icon
4477
Mercer International
MERC
$28.4M
$149K ﹤0.01%
11,347
-42,865
-79% -$635K
MCRB icon
4478
Seres Therapeutics
MCRB
$51.2M
$148K ﹤0.01%
2,157
-2,625
-55% -$226K
DRIO icon
4479
DarioHealth
DRIO
$70.7M
$147K ﹤0.01%
1,196
+653
+120% +$76.6K
SABR icon
4480
CALL
Sabre
SABR
$916M
$147K ﹤0.01%
25,300
HBIO icon
4481
Harvard Bioscience
HBIO
$34.4M
$146K ﹤0.01%
+4,069
New +$184K
CANO.WS
4482
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$146K ﹤0.01%
+215,000
New +$223K
ROIVW
4483
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$146K ﹤0.01%
+242,918
New +$127K
RFL icon
4484
Rafael Holdings
RFL
$117M
$145K ﹤0.01%
78,559
-19,424
-20% -$38.7K
RUMBW
4485
RUM Group Inc Warrant
RUMBW
$22M
$145K ﹤0.01%
107,072
ANNX icon
4486
Annexon
ANNX
$973M
$144K ﹤0.01%
38,326
-125,053
-77% -$382K
APYX icon
4487
Apyx Medical
APYX
$131M
$144K ﹤0.01%
+24,586
New +$126K
OPTU
4488
CALL
Optimum Communications Inc
OPTU
$357M
$144K ﹤0.01%
15,600
-48,600
-76% -$509K
CBIO
4489
Crescent Biopharma
CBIO
$640M
$144K ﹤0.01%
2,420
-137
-5% -$10.1K
CAAP icon
4490
Corporacion America
CAAP
$4.05B
$143K ﹤0.01%
25,623
+8,338
+48% +$51.5K
FPH icon
4491
Five Point Holdings
FPH
$365M
$143K ﹤0.01%
36,650
-5,828
-14% -$30.1K
GHY
4492
PGIM Global High Yield Fund
GHY
$474M
$143K ﹤0.01%
12,500
TNYA icon
4493
Tenaya Therapeutics
TNYA
$156M
$143K ﹤0.01%
25,440
-13,076
-34% -$106K
NUTX
4494
Nutex Health
NUTX
$1.26B
$141K ﹤0.01%
+292
New +$344K
WHWK
4495
Whitehawk Therapeutics
WHWK
$283M
$140K ﹤0.01%
+11,395
New +$169K
SILV
4496
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$140K ﹤0.01%
22,900
-1,993
-8% -$15.1K
FUV
4497
DELISTED
Arcimoto, Inc. Common Stock
FUV
$140K ﹤0.01%
2,146
-101
-4% -$8.01K
HIO
4498
Western Asset High Income Opportunity Fund
HIO
$331M
$139K ﹤0.01%
35,000
PRCH icon
4499
Porch Group
PRCH
$1.98B
$139K ﹤0.01%
54,111
+42,679
+373% +$177K
TKC icon
4500
Turkcell
TKC
$4.71B
$137K ﹤0.01%
54,723
+235
+0.4% +$760

Similar funds

David Shaw's Q2 2022 Portfolio in Review

As of Q2 2022, David Shaw held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

David Shaw withdrew a net $8.25B in Q2 2022, closing 791 positions and reducing 1,835 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, David Shaw opened a new position in iShares MSCI Emerging Markets ETF worth $171M.

  • David Shaw's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
  • David Shaw added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
  • David Shaw's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
  • David Shaw fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
  • David Shaw's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
  • David Shaw opened 595 new positions and closed 791 in Q2 2022.
  • David Shaw's portfolio value fell 20% quarter-over-quarter to $85.3B.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.